Cardiovascular and Cerebrovascular Events in the Randomized, Controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

OBJECTIVES: The Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) was designed to evaluate the conventional NSAID naproxen sodium and the selective COX-2 inhibitor celecoxib for primary prevention of Alzheimer's dementia (AD). On 17 December 2004, after the Adenoma Prevention...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851724/
https://www.ncbi.nlm.nih.gov/pubmed/17111043
http://dx.doi.org/10.1371/journal.pctr.0010033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851724/
https://www.ncbi.nlm.nih.gov/pubmed/17111043
http://dx.doi.org/10.1371/journal.pctr.0010033

Ejemplares similares